JOURNAL OF CHEMICAL RESEARCH 2007 441
References
123.2 (C-5), 51.0 (OCH3). IR (KBr): 3070-3008 (w, Ar–CH),
2960–2860 (m, aliph.-CH), 1695 (s, CO), 1612 (s, C=N), 1540 (m,
C=C), 1450 (s), 918 (m) cm-1. lmax (CH3CN, lg e, nm): 360 (3.4). MS
(m/z,%): 430 [M+] (100), 353 (32), 338 (22), 260 (26), 150 (60), 108
(42), 77 (30). C29H22N2O2 (430.51): Calcd: C, 80.91; H, 5.15; N,
6.51. Found: C, 80.80; H, 5.10; N, 6.50.
1
M. Takahashi, Y. Kadowaki, Y. Uno and Y. Nakamoto, Heterocycles,ꢀ
1999, 51, 2035, and references therein.
2
(a) H. Kogen, T. Kiho, K. Tago, S. Miyamoto, T. Fujioka, N. Otsuka,
K. Suzuki-Konagai and T. Ogita, J.ꢀAm.ꢀChem.ꢀSoc.,ꢀ2000, 122, 1842;
(b) F. Bohlmann, J. Jakupovic, L. Mueller and A. Schuster, Angew.ꢀChem.,ꢀ
Int.ꢀEd.ꢀEngl., 1981, 20, 292.
3-(4-Methylphenyl)-2,5,6-triphenylpyrimidin-4(3H)-oneꢀ
(5b):
3
(a) M.E. Vol’pin, Yu.D. Koreshkov and D.N. Kursanov, Izv.ꢀAkd.ꢀNaukꢀ
SSSR,ꢀ Otd.ꢀ Khim.ꢀ Nauk, 1959, 560; (b) R. Breslow, R. Haynie and
J. Mirra, J.ꢀAm.ꢀChem.ꢀSoc.,ꢀ1959, 81, 247.
Compound 5b was obtained as yellow crystals (0.32 g, 76%), m.p.
263–265°C [lit.20 262–264].
3-(4-Chlorophenyl)-2,5,6-triphenylpyrimidin-4(3H)-one
(5c):
4
5
R. Breslow, J. Posner and A. Krebs, J.ꢀAm.ꢀChem.ꢀSoc.,ꢀ1963, 85, 234.
R. Breslow, T. Eicher, A. Krebs, R.A. Peterson and J. Posner, J.ꢀ Am.ꢀ
Chem.ꢀSoc.,ꢀ1965, 87, 1320.
Compound 5c was obtained as pale yellow crystals (0.30 g, 70%),
m.p. 192°C (ethanol). 1H NMR: d = 7.56–7.50 (m, 2 H, Ph–H),
7.40–7.12 (m, 7 H, H-16,20), 7.00–6.80 (m, 6 H, Ph–H), 6.75–6.64
(m, 4 H, Ph–H). 13C NMR: d = 168.0 (C-4), 162.0 (C-2), 145.2
(C-6), 134.0 (Cl–Ph–C), 130.4, 129.6, 128.8, 128.4 (Ph-C), 128.0,
127.8, 127.6, 127.2 (ortho-2Ph–CH), 127.0, 126.8, 126.4 (meta-
2Ph–CH), 126.6, 126.4, 126.0 (para-Ph–CH), 123.0 (C-5), 121.0
(Cl-2Ph–CH). IR (KBr): 3080–2990 (m, Ar–CH), 1690 (s, CO), 1612
(s, C=N), 1580 (s, C=C), 916 (m) cm-1. lmax (CH3CN, lg e, nm): 348
(3.4). MS (m/z,%): 435 [M + 2] (30), 434 [M+] (100), 356 (24), 323
(24), 321 (28), 246 (24), 244 (28), 192 (32), 190 (54), 114 (24), 112
(36), 77 (50). C28H19ClN2O (434.93): Calcd; C, 77.33; H, 4.40; Cl,
8.15; N, 6.44. Found; C, 77.46; H, 4.36; Cl, 8.10; N, 6.39.
6
For representative papers see: (a) A. Kascheres, H.C. Schumacher and
R.A.F. Rodrigues,ꢀJ.ꢀHeterocycl.ꢀChem., 1997, 34, 757; (b) A. Kascheres
and R.A.F. Rodrigues, Tetrahedron,ꢀ1996, 52, 12919, (c) A. Kascheres,
C. Kascheres and A.C.H. Braga, J.ꢀOrg.ꢀChem.,ꢀ1993, 58, 1702.
T. Eicher and J.L. Weber, TetrahedronꢀLett., 1974, 1381.
T. Eicher, F. Abdesaken, G. Franke and J.L. Weber, Tetrahedronꢀ Lett.,
1975, 3915.
7
8
9
T. Eicher, J.L. Weber and G. Chatila, LiebigsꢀAnn.ꢀChem.,ꢀ1978, 1203.
10 T. Eicher and D. Krause, TetrahedronꢀLett.,ꢀ1979, 1213.
11 T. Eicher and G. Franke, LiebigsꢀAnn.ꢀChem.,ꢀ1981, 1337.
12 T. Eicher and D. Krause, Synthesis, 1986, 899.
13 T. Okawara, R. Kato, T. Yamasaki, N. Yasuda and M. Furukawa,
Heterocycles, 1986, 24, 4.
14 V. Bilinski, A.M. Steinfels and A.S. Dreiding, Helv.ꢀChim.ꢀActa,ꢀ1972,
55, 1065.
15 K.A. Jensen, H.R. Baccaro, O. Buchardt, G.G. Olsen, C. Pedersen and
J. Toft,ꢀActaꢀChem.ꢀScand., 1961, 15, 1109.
16 A.H. de Vries, J. Brussee and A.P.ꢀIjzerman,ꢀJ.ꢀMed.ꢀChem.,ꢀ2005, 48,ꢀ1145.
17 V.S. Zyabrev, M.A. Rensky, E.B. Rusanov and B.S. Drach, Heteroatomꢀ
Chem., 2003, 14, 474.
18 A.A. Aly, A.A. Hassan, M.A.-M. Gomaa and E.M. El-Sherief, Arkivoc.,
2007, xiv, 1.
19 A.A. Aly, E.K. Ahmed and K.M. El-Mokadam, J.ꢀSulf. Chem., 2007, 28, 285.
20 A.A. Aly, J.Chem.Res., 2007, 451.
21 H. Yoshida, S. Sogame, Y. Takishita and T. Ogata, BullꢀChem.ꢀSoc. Jpn.,
1983, 56, 2438.
22 R.A.Y. Jones and N. Sadighi, J.ꢀChem.ꢀSoc.,ꢀPerkinꢀTransꢀ1, 1976, 2259.
23 R.A.Y. Jones and N. Sadighi, J.ꢀChem.ꢀSoc.,ꢀPerkinꢀTransꢀ2, 1977, 412.
24 T.L. Gilchrist, C.J. Harris and C.W. Rees, J.ꢀChem.ꢀSoc.,ꢀChem.ꢀCommun.,ꢀ
1974, 487.
3-(4-Nitrophenyl)-2,5,6-triphenylpyrimidin-4(3H)-one
(5d):
Compound 5d was obtained as pale orange crystals (0.21 g, 60%),
1
m.p. 250°C (methanol). H NMR: d = 8.10 (dd, 2 H, J = 8.0,
1.2 Hz, NO2Ph), 7.80 (dd, 2 H, J = 8.0, 1.2 Hz, NO2Ph), 7.60–7.20
(m, 8 H, Ph–H), 7.00–6.80 (m, 7 H, Ph–H). 13C NMR: d = 169.4
(C-4), 161.0 (C-2), 144.2 (C-6), 143.8 (N–C–PhNO2), 140.2
(NO2–Ph–C), 132.4, 132.0, 130.8 (Ph–C), 129.6, 129.4, 129.0
(ortho-2Ph–CH), 128.6, 128.4, 128.0 (meta-2Ph–CH), 127.4, 127.0,
126.0 (para-Ph–CH), 124.0 (NO2–2PhCH), 123.2 (C-5), 120.0
(NO2–2PhCH). IR (KBr): 3070–2990 (w, Ar–CH), 1700 (CO), 1610
(s, C=N), 1496 (s, C=C), 920 (s) cm-1. lmax (CH3CN, lg e, nm): 340
(3.3). MS (m/z,%): 445 [M+] (100), 368 (32), 322 (30), 290 (24),
262 (16), 246 (30), 240 (34), 192 (30), 169 (24), 122 (28), 77 (40).
C28H19N3O3 (445.48) Calcd; C, 75.49; H, 4.30; N, 9.43. Found; C,
75.30; H, 4.22; N, 9.40.
2,3,5,6-Tetraphenylpyrimidin-4(3H)-one (5e): Compound 5e was
obtained as yellow crystals (0.25 g, 74%), m.p. 296°C [lit.22,25 295–
296°C].
25 T.L. Gilchrist, C.J. Harris, C.J. Moody and C.W. Rees, J.ꢀ Chem.ꢀ Soc.,ꢀ
PerkinꢀTransꢀ1, 1975, 1969.
26 (a) F.J. Giles, E.J. Feldman, G.J. Roboz, R.A. Larson, S.W. Mamus, J.E. Cortes,
S. Verstovsek, S. Federl, M. Talpaz, M. Beran, M. Albitar, S.M. O’Brien and
H.M. Kantarjian, Leuk.ꢀRes.,ꢀ2003, 27, 1091; (b) T.J. Mangner, R.W. Klecker,
L. Anderson andA.F. Shields, Nucl.ꢀMed.ꢀBiol.,ꢀ2003, 30, 215.
27 A. Arnaud, L. Fontana, A.J. Angulo, Á. Gil and J.M. López-Pedrosa, Clin.ꢀ
Nutr., 2003, 22, 391.
28 A. Kumar, S. Sinha and P.S. Chauhan, Bioorg.ꢀMed.ꢀChem.ꢀLett.,ꢀ2002,
12, 667.
29 J.B. Bher, T. Gourlain, A. Helimi and G. Guillerm, Bioorg.ꢀMed.ꢀChem.ꢀ
Lett.,ꢀ2003, 13, 1713.
Prof Dr Ashraf A. Aly thanks the DAAD foundation for
financial support to stay in Germany, Braunschweig, Institute
for Organic Chemistry.
Receivedꢀ31ꢀMayꢀ2007;ꢀacceptedꢀ16ꢀJulyꢀ2007ꢀ
Paperꢀ07/4676ꢀ doi:ꢀ10.3184/030823407X234563
PAPER: 07/4676